-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Evolent Health, Raises Price Target to $6

Benzinga·08/18/2026 14:19:59
Listen to the news
JP Morgan analyst John Stansel maintains Evolent Health (NYSE:EVH) with a Overweight and raises the price target from $5 to $6.